Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
143 | EPC - European Pharmaceutical Contractor | journal | 3 | 7 | 0 | 20 | 0 | 0 | 0.00 | 2.86 | 28.57 | ||
142 | European Journal of Parenteral and Pharmaceutical Sciences | journal | 0.166 Q3 | 7 | 13 | 35 | 214 | 10 | 34 | 0.24 | 16.46 | 30.77 | |
141 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.726 Q2 | 13 | 18 | 47 | 751 | 163 | 41 | 3.74 | 41.72 | 36.17 | |
140 | Expert Review of Precision Medicine and Drug Development | journal | 0.257 Q3 | 16 | 3 | 102 | 251 | 92 | 79 | 0.90 | 83.67 | 42.86 | |
139 | International Journal of Computational Biology and Drug Design | journal | 0.120 Q4 | 16 | 14 | 80 | 527 | 27 | 79 | 0.50 | 37.64 | 35.56 | |
138 | Toxicon: X | journal | 0.870 Q1 | 16 | 20 | 97 | 1404 | 356 | 96 | 4.11 | 70.20 | 35.77 | |
137 | Journal of Cannabis Research | journal | 0.692 Q2 | 17 | 39 | 148 | 1666 | 627 | 144 | 4.35 | 42.72 | 47.62 | |
136 | Journal of Biologically Active Products from Nature | journal | 0.243 Q3 | 18 | 39 | 112 | 1772 | 149 | 111 | 1.14 | 45.44 | 36.22 | |
135 | Journal of Pharmaceutical Health Services Research | journal | 0.206 Q3 | 19 | 56 | 205 | 1960 | 134 | 192 | 0.51 | 35.00 | 48.76 | |
134 | Pharmaceutical patent analyst | journal | 0.351 Q2 | 20 | 26 | 62 | 1235 | 71 | 50 | 1.18 | 47.50 | 39.62 | |
133 | Pharmaceutical Medicine | journal | 0.732 Q2 | 25 | 47 | 107 | 2050 | 275 | 93 | 2.59 | 43.62 | 41.73 | |
132 | Statistics in Biopharmaceutical Research | journal | 0.978 Q1 | 25 | 121 | 196 | 3714 | 312 | 161 | 0.88 | 30.69 | 37.50 | |
131 | Expert Opinion on Orphan Drugs | journal | 0.199 Q3 | 27 | 3 | 85 | 174 | 66 | 82 | 0.86 | 58.00 | 30.00 | |
130 | Pharmaceutical Journal | journal | 0.115 Q4 | 28 | 71 | 1739 | 570 | 90 | 1643 | 0.05 | 8.03 | 57.81 | |
129 | Journal of Pharmaceutical Policy and Practice | journal | 0.740 Q1 | 32 | 165 | 291 | 6518 | 936 | 256 | 2.71 | 39.50 | 44.97 | |
128 | Drug Discovery Today: Disease Models | journal | 0.665 Q2 | 33 | 0 | 23 | 0 | 64 | 20 | 0.00 | 0.00 | 0.00 | |
127 | Current Opinion in Systems Biology | journal | 1.676 Q1 | 34 | 21 | 140 | 1378 | 455 | 131 | 3.24 | 65.62 | 33.93 | |
126 | npj Systems Biology and Applications | journal | 1.248 Q1 | 35 | 61 | 127 | 3945 | 467 | 126 | 3.68 | 64.67 | 32.92 | |
125 | Birth Defects Research | journal | 0.557 Q3 | 36 | 145 | 377 | 6707 | 753 | 341 | 1.68 | 46.26 | 61.75 | |
124 | Drugs in Context | journal | 0.811 Q2 | 36 | 58 | 193 | 3370 | 574 | 193 | 2.46 | 58.10 | 41.20 | |
123 | Personalized Medicine | journal | 0.412 Q3 | 36 | 43 | 146 | 1840 | 255 | 138 | 1.62 | 42.79 | 49.20 | |
122 | Cutaneous and Ocular Toxicology | journal | 0.457 Q3 | 37 | 42 | 153 | 1584 | 277 | 149 | 1.74 | 37.71 | 43.68 | |
121 | Advanced Therapeutics | journal | 1.063 Q1 | 39 | 159 | 324 | 12890 | 1482 | 319 | 4.31 | 81.07 | 44.77 | |
120 | Environmental Pollutants and Bioavailability | journal | 0.659 Q2 | 39 | 53 | 114 | 3294 | 424 | 113 | 3.90 | 62.15 | 44.88 | |
119 | Food Additives and Contaminants: Part B Surveillance | journal | 0.557 Q3 | 41 | 39 | 107 | 1681 | 336 | 107 | 3.07 | 43.10 | 51.12 | |
118 | Journal of Venomous Animals and Toxins Including Tropical Diseases | journal | 0.453 Q3 | 41 | 20 | 131 | 1498 | 307 | 131 | 2.19 | 74.90 | 51.58 | |
117 | BMC pharmacology & toxicology | journal | 0.710 Q2 | 43 | 77 | 253 | 2925 | 763 | 253 | 2.92 | 37.99 | 43.47 | |
116 | Pharmacology Research and Perspectives | journal | 0.790 Q1 | 43 | 112 | 456 | 3704 | 1368 | 443 | 2.93 | 33.07 | 44.55 | |
115 | International Journal of Pharmacy Practice | journal | 0.493 Q2 | 44 | 89 | 276 | 2806 | 440 | 244 | 1.38 | 31.53 | 59.75 | |
114 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 0.471 Q2 | 46 | 40 | 122 | 2294 | 361 | 122 | 2.52 | 57.35 | 48.99 | |
113 | Pharmaceutical Statistics | journal | 1.074 Q1 | 46 | 80 | 266 | 2401 | 460 | 252 | 1.77 | 30.01 | 32.74 | |
112 | Journal of Occupational Medicine and Toxicology | journal | 0.868 Q1 | 47 | 31 | 109 | 1321 | 366 | 108 | 3.10 | 42.61 | 44.30 | |
111 | npj Vaccines | journal | 2.127 Q1 | 47 | 182 | 421 | 9795 | 2689 | 404 | 6.60 | 53.82 | 45.87 | |
110 | Toxicology Research | journal | 0.505 Q3 | 47 | 102 | 309 | 5483 | 749 | 307 | 2.28 | 53.75 | 47.64 | |
109 | Mathematical Medicine and Biology | journal | 0.276 Q3 | 49 | 15 | 63 | 536 | 67 | 63 | 1.10 | 35.73 | 33.33 | |
108 | Journal of Asian Natural Products Research | journal | 0.339 Q3 | 51 | 176 | 394 | 4241 | 720 | 372 | 1.94 | 24.10 | 39.79 | |
107 | EPMA Journal | journal | 1.370 Q1 | 52 | 41 | 114 | 3583 | 830 | 111 | 7.32 | 87.39 | 43.01 | |
106 | Cardiovascular Therapeutics | journal | 0.769 Q2 | 54 | 34 | 165 | 1509 | 544 | 165 | 3.43 | 44.38 | 38.42 | |
105 | Drugs in R and D | journal | 0.708 Q2 | 54 | 40 | 111 | 1687 | 296 | 107 | 2.41 | 42.18 | 50.97 | |
104 | Expert Opinion on Emerging Drugs | journal | 0.881 Q2 | 54 | 29 | 110 | 2695 | 321 | 102 | 2.62 | 92.93 | 36.28 | |
103 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.326 Q3 | 54 | 51 | 154 | 1785 | 212 | 134 | 0.86 | 35.00 | 22.94 | |
102 | SAR and QSAR in Environmental Research | journal | 0.359 Q3 | 54 | 49 | 147 | 2680 | 414 | 147 | 2.58 | 54.69 | 35.87 | |
101 | Toxin Reviews | journal | 0.552 Q3 | 54 | 55 | 296 | 4100 | 1082 | 294 | 3.84 | 74.55 | 41.88 | |
100 | Toxicology Mechanisms and Methods | journal | 0.693 Q2 | 55 | 80 | 208 | 4381 | 824 | 205 | 3.06 | 54.76 | 42.70 | |
99 | Biomarkers in Medicine | journal | 0.481 Q3 | 56 | 91 | 431 | 3625 | 801 | 414 | 1.70 | 39.84 | 37.91 | |
98 | Chinese Medicine | journal | 0.877 Q2 | 56 | 159 | 409 | 11306 | 2115 | 406 | 5.30 | 71.11 | 43.23 | |
97 | Journal of Chemotherapy | journal | 0.439 Q3 | 56 | 125 | 197 | 5160 | 347 | 179 | 1.80 | 41.28 | 46.01 | |
96 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.696 Q2 | 57 | 27 | 169 | 1330 | 433 | 166 | 2.60 | 49.26 | 34.83 | |
95 | DARU, Journal of Pharmaceutical Sciences | journal | 0.625 Q2 | 58 | 43 | 149 | 2213 | 587 | 146 | 2.80 | 51.47 | 51.06 | |
94 | Antiviral Chemistry and Chemotherapy | journal | 0.369 Q3 | 59 | 2 | 29 | 41 | 62 | 28 | 0.87 | 20.50 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®